. 2022 Jan 19;7(3):268–276. doi: 10.1001/jamacardio.2021.5617

Table 4. Adjusted Association of Baseline N-Terminal Pro–Brain Natriuretic Peptide (NT-proBNP) and Blood Pressure With Development of Hypertension at 2 to 7 Years After Delivery^a^,^b.

Measure	Hypertension, adjusted OR (95% CI)
Measure	No (n = 3276)	Yes (n = 817)
NT-proBNP, median (IQR), pg/mL	64.0 (41.0-96.0)	54.0 (35.0-83.0)
NT-proBNP, per doubling in value	1 [Reference]	0.82 (0.74-0.89)^c
NT-proBNP, per doubling in value, controlling for systolic blood pressure	1 [Reference]	0.84 (0.77-0.93)^c

Abbreviation: OR, odds ratio.

^{^a}

Adjusted for age, race and ethnicity, body mass index, smoking, and aspirin use.

^{^b}

This characteristic is included in statistical models after a logarithm transformation (base, 2). ORs for log-transformed quantities are interpreted on the multiplicative scale.

^{^c}

P < .05.

Table 4. Adjusted Association of Baseline N-Terminal Pro–Brain Natriuretic Peptide (NT-proBNP) and Blood Pressure With Development of Hypertension at 2 to 7 Years After Deliverya,b.

Table 4. Adjusted Association of Baseline N-Terminal Pro–Brain Natriuretic Peptide (NT-proBNP) and Blood Pressure With Development of Hypertension at 2 to 7 Years After Delivery^a^,^b.